Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc. (BSPM) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001418133 · BSPM · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001418133 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Biostar Pharmaceuticals, Inc. (OTC: BSPM) has submitted 209 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2008. As a Healthcare sector company with CIK 0001418133, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Biostar Pharmaceuticals, Inc.'s most comprehensive regulatory disclosure. The most recent Biostar Pharmaceuticals, Inc. 10-K was filed on 2017-04-13 for fiscal year ending 2017. Historical BSPM 10-K annual reports are available from 2007 through 2017.
Investors researching Biostar Pharmaceuticals, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
BSPM SEC Filings · 8 questionsBiostar Pharmaceuticals, Inc. (BSPM) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 209 filings and access original documents at no cost. Biostar Pharmaceuticals, Inc.'s CIK is 0001418133.